The antidepressant-like effect of vagus nerve stimulation is mediated through the locus coeruleus

Journal of Psychiatric Research

Volumn 68, Issue , 2015, Pages 1-7

  Grimonprez, Annelies ^a   Raedt, Robrecht ^a   Portelli, Jeanelle ^a,b   Dauwe, Ine ^a   Larsen, Lars Emil ^a   Bouckaert, Charlotte ^a   Delbeke, Jean ^a   Carrette, Evelien ^a   Meurs, Alfred ^a   De Herdt, Veerle ^a   Boon, Paul ^a   Vonck, Kristl ^a  

^a GHENT UNIVERSITY   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Depression; Forced swim test; Locus coeruleus; Noradrenaline; Vagus nerve stimulation

Indexed keywords

2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; DOPAMINE BETA MONOOXYGENASE; NEUROTOXIN; NORADRENALIN; BENZYLAMINE DERIVATIVE; NEUROTRANSMITTER UPTAKE INHIBITOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN HISTOLOGY; BRAIN STEM; CONTROLLED STUDY; DEPRESSION; FORCED SWIM TEST; HIPPOCAMPUS; IMMOBILITY; IMMUNOHISTOCHEMISTRY; LOCOMOTION; LOCUS CERULEUS; MALE; NONHUMAN; NORADRENERGIC NERVE CELL; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; VAGUS NERVE STIMULATION; ANIMAL; DISEASE MODEL; DRUG EFFECTS; EXPLORATORY BEHAVIOR; METABOLISM; NONPARAMETRIC TEST; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY; SWIMMING; TREATMENT OUTCOME; WISTAR KYOTO RAT;

ANIMALS; BENZYLAMINES; DEPRESSION; DISEASE MODELS, ANIMAL; DOPAMINE BETA-HYDROXYLASE; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; MALE; NEUROTRANSMITTER UPTAKE INHIBITORS; RATS; RATS, INBRED WKY; STATISTICS, NONPARAMETRIC; SWIMMING; TREATMENT OUTCOME; TYROSINE 3-MONOOXYGENASE; VAGUS NERVE STIMULATION;

EID: 84937870561     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2015.05.002     Document Type: Article

References (73)

1. Airan R.D., Meltzer L.A., Roy M., Gong Y., Chen H., Deisseroth K. High-speed imaging reveals neurophysiological links to behavior in an animal model of depression. Science 2007, 317:819-823.
2. Bajbouj M., Merkl A., Schlaepfer T.E., Frick C., Zobel A., Maier W., et al. Two-year outcome of vagus nerve stimulation in treatment-resistant depression. JClin Psychopharmacol 2010, 30:273-281.
3. Ben-Menachem E. Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurol 2002, 1:477-482.
4. Biggio F., Gorini G., Utzeri C., Olla P., Marrosu F., Mocchetti I., et al. Chronic vagus nerve stimulation induces neuronal plasticity in the rat hippocampus. Int J Neuropsychopharmacol 2009, 12:1209-1221.
5. Carpenter L.L., Moreno F.A., Kling M.A., Anderson G.M., Regenold W.T., Labiner D.M., et al. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients. Biol Psychiatry 2004, 56:418-426.
6. Cohen Z., Molinatti G., Hamel E. Astroglial and vascular interactions of noradrenaline terminals in the rat cerebral cortex. JCereb Blood Flow Metab 1997, 17:894-904.
7. Cristancho P., Cristancho M.A., Baltuch G.H., Thase M.E., O'Reardon J.P. Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year. JClin Psychiatry 2011, 72:1376-1382.
8. Cryan J.F., Page M.E., Lucki I. Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test. Eur J Pharmacol 2002, 436:197-205.
9. Danysz W., Kostowski W., Kozak W., Hauptmann M. On the role of noradrenergic neurotransmission in the action of desipramine and amitriptyline in animal models of depression. Pol J Pharmacol Pharm 1986, 38:285-298.
10. Dorr A.E., Debonnel G. Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. JPharmacol Exp Ther 2006, 318:890-898.
11. Duman R.S., Nakagawa S., Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 2001, 25:836-844.
12. Dunlop B.W., Nemeroff C.B. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 2007, 64:327-337.
13. Elger G., Hoppe C., Falkai P., Rush A.J., Elger C.E. Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res 2000, 42:203-210.
14. Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003, 53:649-659.
15. Florin-Lechner S.M., Druhan J.P., Aston-Jones G., Valentino R.J. Enhanced norepinephrine release in prefrontal cortex with burst stimulation of the locus coeruleus. Brain Res 1996, 742:89-97.
16. Follesa P., Biggio F., Gorini G., Caria S., Talani G., Dazzi L., et al. Vagus nerve stimulation increases norepinephrine concentration and the gene expression of BDNF and bFGF in the rat brain. Brain Res 2007, 1179:28-34.
17. Fritschy J.M., Grzanna R. Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals. Neuroscience 1989, 30:181-197.
18. Fritschy J.M., Grzanna R. Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system?. Prog Brain Res 1991, 88:257-268.
19. Furmaga H., Carreno F.R., Frazer A. Vagal nerve stimulation rapidly activates brain-derived neurotrophic factor receptor TrkB in rat brain. PLoS One 2012, 7:e34844.
20. Furmaga H., Shah A., Frazer A. Serotonergic and noradrenergic pathways are required for the anxiolytic-like and antidepressant-like behavioral effects of repeated vagal nerve stimulation in rats. Biol Psychiatry 2011, 70:937-945.
21. Gebhardt N., Bar K.J., Boettger M.K., Grecksch G., Keilhoff G., Reichart R., et al. Vagus nerve stimulation ameliorated deficits in one-way active avoidance learning and stimulated hippocampal neurogenesis in bulbectomized rats. Brain Stimul 2013, 6:78-83.
22. George M.S., Rush A.J., Marangell L.B., Sackeim H.A., Brannan S.K., Davis S.M., et al. Aone-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry 2005, 58:364-373.
23. Grenhoff J., Nisell M., Ferre S., Aston-Jones G., Svensson T.H. Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. JNeural Transm Gen Sect 1993, 93:11-25.
24. Grenhoff J., Svensson T.H. Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. Eur J Pharmacol 1993, 233:79-84.
25. Grimonprez A., Raedt R., Dauwe I., Mollet L., Larsen L.E., Meurs A., et al. Vagus nerve stimulation has antidepressant effects in the kainic acid model for temporal lobe epilepsy. Brain Stimul 2015, 8:13-20.
26. Groves D.A., Bowman E.M., Brown V.J. Recordings from the rat locus coeruleus during acute vagal nerve stimulation in the anaesthetised rat. Neurosci Lett 2005, 379:174-179.
27. Guiard B.P., El Mansari M., Merali Z., Blier P. Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions. Int J Neuropsychopharmacol 2008, 11:625-639.
28. Harden C.L. Depression and anxiety in epilepsy patients. Epilepsy Behav 2002, 3:296.
29. Harro J., Oreland L. Depression as a spreading adjustment disorder of monoaminergic neurons: a case for primary implication of the locus coeruleus. Brain Res Brain Res Rev 2001, 38:79-128.
30. Hartman B.K., Zide D., Udenfriend S. The use of dopamine -hydroxylase as a marker for the central noradrenergic nervous system in rat brain. Proc Natl Acad Sci U S A 1972, 69:2722-2726.
31. Hassert D.L., Miyashita T., Williams C.L. The effects of peripheral vagal nerve stimulation at a memory-modulating intensity on norepinephrine output in the basolateral amygdala. Behav Neurosci 2004, 118:79-88.
32. Jhaveri D.J., Mackay E.W., Hamlin A.S., Marathe S.V., Nandam L.S., Vaidya V.A., et al. Norepinephrine directly activates adult hippocampal precursors via beta3-adrenergic receptors. JNeurosci 2010, 30:2795-2806.
33. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003, 289:3095-3105.
34. Kostowski W., Danysz W., Plaznik A., Nowakowska E. Studies on the locus coeruleus system in an animal model for antidepressive activity. Pol J Pharmacol Pharm 1984, 36:523-530.
35. Kostowski W., Jerlicz M., Bidzinski A., Hauptmann M. Evidence for existence of two opposite noradrenergic brain systems controlling behavior. Psychopharmacology (Berl) 1978, 59:311-312.
36. Krahl S.E., Clark K.B. Vagus nerve stimulation for epilepsy: a review of central mechanisms. Surg Neurol Int 2012, 3:S255-S259.
37. Krahl S.E., Clark K.B., Smith D.C., Browning R.A. Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia 1998, 39:709-714.
38. Krahl S.E., Senanayake S.S., Pekary A.E., Sattin A. Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action. JPsychiatr Res 2004, 38:237-240.
39. Labar D. Vagus nerve stimulation for 1 year in 269 patients on unchanged antiepileptic drugs. Seizure 2004, 13:392-398.
40. Liporace J., Hucko D., Morrow R., Barolat G., Nei M., Schnur J., et al. Vagal nerve stimulation: adjustments to reduce painful side effects. Neurology 2001, 57:885-886.
41. Loy R., Koziell D.A., Lindsey J.D., Moore R.Y. Noradrenergic innervation of the adult rat hippocampal formation. JComp Neurol 1980, 189:699-710.
42. Manta S., Dong J., Debonnel G., Blier P. Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation. JPsychiatry Neurosci 2009, 34:272-280.
43. Manta S., El Mansari M., Blier P. Novel attempts to optimize vagus nerve stimulation parameters on serotonin neuronal firing activity in the rat brain. Brain Stimul 2012, 5:422-429.
44. Manta S., El Mansari M., Debonnel G., Blier P. Electrophysiological and neurochemical effects of long-term vagus nerve stimulation on the rat monoaminergic systems. Int J Neuropsychopharmacol 2012, 1-12.
45. Manta S., El Mansari M., Debonnel G., Blier P. Electrophysiological and neurochemical effects of long-term vagus nerve stimulation on the rat monoaminergic systems. Int J Neuropsychopharmacol 2013, 16:459-470.
46. Marangell L.B., Rush A.J., George M.S., Sackeim H.A., Johnson C.R., Husain M.M., et al. Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry 2002, 51:280-287.
47. Moret C., Briley M. The importance of norepinephrine in depression. Neuropsychiatr Dis Treat 2011, 7:9-13.
48. Nahas Z., Marangell L.B., Husain M.M., Rush A.J., Sackeim H.A., Lisanby S.H., et al. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. JClin Psychiatry 2005, 66:1097-1104.
49. Nyback H.V., Walters J.R., Aghajanian G.K., Roth R.H. Tricyclic antidepressants: effects on the firing rate of brain noradrenergic neurons. Eur J Pharmacol 1975, 32:302-312.
50. Owens M.J., Nemeroff C.B. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 1994, 40:288-295.
51. Pare W.P. Stress ulcer susceptibility and depression in Wistar Kyoto (WKY) rats. Physiol Behav 1989, 46:993-998.
52. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978, 47:379-391.
53. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
54. Raedt R., Clinckers R., Mollet L., Vonck K., El Tahry R., Wyckhuys T., et al. Increased hippocampal noradrenaline is a biomarker for efficacy of vagus nerve stimulation in a limbic seizure model. JNeurochem 2011, 117:461-469.
55. Randich A., Gebhart G.F. Vagal afferent modulation of nociception. Brain Res Brain Res Rev 1992, 17:77-99.
56. Randich A., Ren K., Gebhart G.F. Electrical stimulation of cervical vagal afferents. II. Central relays for behavioral antinociception and arterial blood pressure decreases. JNeurophysiol 1990, 64:1115-1124.
57. Ren K., Randich A., Gebhart G.F. Electrical stimulation of cervical vagal afferents. I. Central relays for modulation of spinal nociceptive transmission. JNeurophysiol 1990, 64:1098-1114.
58. Revesz D., Tjernstrom M., Ben-Menachem E., Thorlin T. Effects of vagus nerve stimulation on rat hippocampal progenitor proliferation. Exp Neurol 2008, 214:259-265.
59. Rizk P., Salazar J., Raisman-Vozari R., Marien M., Ruberg M., Colpaert F., et al. The alpha2-adrenoceptor antagonist dexefaroxan enhances hippocampal neurogenesis by increasing the survival and differentiation of new granule cells. Neuropsychopharmacology 2006, 31:1146-1157.
60. Roosevelt R.W., Smith D.C., Clough R.W., Jensen R.A., Browning R.A. Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat. Brain Res 2006, 1119:124-132.
61. Rush A.J., George M.S., Sackeim H.A., Marangell L.B., Husain M.M., Giller C., et al. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry 2000, 47:276-286.
62. Rush A.J., Marangell L.B., Sackeim H.A., George M.S., Brannan S.K., Davis S.M., et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry 2005, 58:347-354.
63. Rush A.J., Sackeim H.A., Marangell L.B., George M.S., Brannan S.K., Davis S.M., et al. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry 2005, 58:355-363.
64. Sackeim H.A., Rush A.J., George M.S., Marangell L.B., Husain M.M., Nahas Z., et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 2001, 25:713-728.
65. Schildkraut J.J. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 1965, 122:509-522.
66. Schlaepfer T.E., Frick C., Zobel A., Maier W., Heuser I., Bajbouj M., et al. Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychol Med 2008, 38:651-661.
67. Scuvee-Moreau J.J., Dresse A.E. Effect of various antidepressant drugs on the spontaneous firing rate of locus coeruleus and dorsal raphe neurons of the rat. Eur J Pharmacol 1979, 57:219-225.
68. Serafini G., Hayley S., Pompili M., Dwivedi Y., Brahmachari G., Girardi P., et al. Hippocampal neurogenesis, neurotrophic factors and depression: possible therapeutic targets?. CNS Neurol Disord Drug Targets 2014, 13:1708-1721.
69. Slattery D.A., Cryan J.F. Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat Protoc 2012, 7:1009-1014.
70. Toussay X., Basu K., Lacoste B., Hamel E. Locus coeruleus stimulation recruits a broad cortical neuronal network and increases cortical perfusion. JNeurosci 2013, 33:3390-3401.
71. Valentino R.J., Curtis A.L., Page M.E., Pavcovich L.A., Florin-Lechner S.M. Activation of the locus ceruleus brain noradrenergic system during stress: circuitry, consequences, and regulation. Adv Pharmacol 1998, 42:781-784.
72. Valentino R.J., Curtis A.L., Parris D.G., Wehby R.G. Antidepressant actions on brain noradrenergic neurons. JPharmacol Exp Ther 1990, 253:833-840.
73. Wainwright S.R., Galea L.A. The neural plasticity theory of depression: assessing the roles of adult neurogenesis and PSA-NCAM within the hippocampus. Neural Plast 2013, 2013:805497.